Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Vancomycin HCl
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : ANI Pharmaceuticals Inc
Deal Size : Undisclosed
Deal Type : Agreement
Edge Pharma Completes Supplier Agreement with ANI Pharmaceuticals, Inc
Details : Edge Pharma has signed an agreement with ANI Pharmaceuticals to market the company's FDA approved Vancomycin Hydrochloride for Oral Solution USP, a generic equivalent to Vancocin®.
Product Name : Vancomycin Hydrochloride-Generic
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
June 25, 2020
Lead Product(s) : Vancomycin HCl
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : ANI Pharmaceuticals Inc
Deal Size : Undisclosed
Deal Type : Agreement